GLP-1 Prescription for Oral Pills: Skip the Needles Entirely
Updated June 2026
⚡ The Oral Revolution
Two FDA-approved oral GLP-1s now exist for weight loss: Foundayo (orforglipron, Eli Lilly — approved April 2026, no food/water restrictions, $149/mo self-pay) and oral Wegovy (semaglutide tablets, Novo Nordisk — approved Dec 2025, empty stomach required). Plus compounded oral options from $249/mo. 20,000 patients started Foundayo in its first month alone, with 35% of prescriptions coming through telehealth.
For years, "GLP-1 medication" meant "weekly injection." That's no longer true. The approval of Foundayo on April 1, 2026, alongside oral Wegovy's December 2025 launch, fundamentally changed the access equation. If needles were your reason for not starting GLP-1 treatment, that reason is now gone.
Eli Lilly's own data tells the story: fewer than 1 in 10 eligible patients are currently on a GLP-1, and needle aversion is one of the top barriers. Foundayo exists specifically to close that gap. In its first month, roughly a third of Foundayo prescribers had never written an oral GLP-1 prescription before — the drug is literally expanding the prescriber base.
Your oral GLP-1 options in June 2026
| Medication | Type | Dosing | Food Rules | Self-Pay Price |
|---|---|---|---|---|
| Foundayo (orforglipron) | FDA-approved | Once daily | None — any time, with food OK | $149/mo |
| Oral Wegovy (semaglutide) | FDA-approved | Once daily | Empty stomach, 30-min wait | $149/mo |
| Compounded oral tablets | Not FDA-approved | Varies | Varies | $249/mo |
| Compounded lozenges/drops | Not FDA-approved | Varies | Sublingual | $199/mo |
Foundayo: the game-changer
Foundayo deserves special attention because it solves problems that even oral Wegovy doesn't. Unlike oral semaglutide (which must be taken on an empty stomach with minimal water, followed by a 30-minute fast), Foundayo can be taken any time of day, with or without food, with no water restrictions. That seemingly small difference matters enormously for real-world adherence. Taking a pill with your morning coffee is dramatically simpler than setting a pre-breakfast alarm for a medication that requires fasting.
Foundayo is also a non-peptide molecule — meaning it's structurally different from semaglutide and tirzepatide. This matters for future affordability: non-peptide drugs are cheaper to manufacture, which means when Foundayo eventually goes generic, it could become one of the most affordable GLP-1 options available.
Clinical trials showed 12.4% average body weight loss at the highest dose over 36 weeks. That's less than injectable tirzepatide (20.9%) but meaningful — and achieved without a single injection.
Where to get an oral GLP-1 prescription
Brand-name oral (Foundayo, oral Wegovy)
Sesame Care
From $149/mo · FDA-approved Wegovy, Ozempic, Zepbound, Foundayo
Brand-name FDA-approved medications with insurance coordination and manufacturer savings card assistance.
Get Started → Paid linkCompounded oral (tablets, lozenges, drops)
FeelGood Telehealth
Injectable $149/mo · Oral tablets $249/mo
The only compounding provider offering both injectable and oral tablet formats. Switch between formats anytime.
Needles Optional → Paid linkStrut Health
From $199/mo · Injectable + oral lozenges
Compounded GLP-1 in both injectable and sublingual lozenge format for needle-free options.
Get Started → Paid linkEden Health
From $149/mo · Injectable + oral drops
Both injectable and oral drop formulations at competitive starting prices.
See Plans → Paid linkCompounded medications are not FDA-approved. Consult a licensed provider.
How to ask for an oral prescription specifically
If you want oral GLP-1 medication, be direct with your provider: "I'm interested in GLP-1 treatment but prefer an oral formulation. Can we start with Foundayo, oral Wegovy, or an oral compounded option?" Most providers will accommodate this preference. If a provider pushes back on oral without a clinical reason, consider a different provider — patient preference for medication format is a legitimate factor in prescribing decisions.
The needle era isn't over — injectable GLP-1s still produce stronger weight loss on average. But the oral era has arrived, and for millions of needle-averse patients, it's the difference between treatment and no treatment at all.